Jeff Zucker?
was thinking Zucker
body frame size Zucker a better fit?
not sure if the same jeff
Jeffrey Zucker, M.B.A.
Strategy Leader
Jeff Zucker has broad experience across the pharmaceutical value chain, spanning the product life cycle from early technology and target assessment, to clinical strategy development and trial design, to commercial and marketing strategies. His expertise includes the integration of physician, payer, and consumer factors into strategic planning and forecasting tools. He has applied this expertise in a wide variety of therapeutic areas and drug categories, including oncology and a variety of other specialty and biologic drug categories.
Jeff has unique experience applying and adapting quantitative research methods to the diverse universe of US payers and managed care organizations. By combining multiple statistical and modeling techniques in innovative ways, Jeff has given clients unusually robust and predictable insight into the behaviors of their key MCO customers.
He is an expert in the identification, validation, and optimization of growth and diversification opportunities for clients in the pharmaceutical, biotechnology, diagnostic, and medical device industries. His entire career has been spent in the healthcare sector, and he has led large client and consulting staff teams through strategic and operational engagements in the U.S. and Europe. Jeff has extensive expertise in the technical and commercial assessment of new technologies and has developed proprietary conceptual and quantitative modeling tools for this purpose. He also has advised numerous leading and emerging pharmaceutical companies on issues including market entry, product development strategy, marketing capabilities, and growth via acquisition or licensing.
Prior to working with the Apical Research Team, Jeff’s 15-year career was split between line management in the pharmaceutical industry and consulting to medical products manufacturers. He performed international clinical development and marketing roles with American Cyanamid, where he developed and managed clinical programs for oncology, cardiovascular, and anti-infective products across Southeast Asia while based in Hong Kong. He also has scientific laboratory experience in the areas of developmental neurobiology and pharmacology.
http://apicalresearch.com/zucker.html
Jeff holds a B.A. in Biology from the University of Chicago and an M.B.A. in Finance from the Wharton School of Business
yeh my money on Zucker but who knows?
Iranian diplomat reportedly arrested in terror plot
by Joel Gehrke
| July 02, 2018 06:00 PM
https://www.washingtonexaminer.com/policy/defense-national-security/iranian-diplomat-reportedly-arrested-in-terror-plot